KD Logo

Amphastar Pharmaceuticals Inc (AMPH) gets rating Initiated from JP Morgan

Amphastar Pharmaceuticals Inc’s recently made public that its CFO, EVP & TREASURER PETERS WILLIAM J unloaded Company’s shares for reported $0.15 million on Jun 27 ’24. In the deal valued at $40.93 per share,3,596 shares were sold. As a result of this transaction, PETERS WILLIAM J now holds 94,103 shares worth roughly $3.48 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Petersen Floyd F. sold 3,000 shares, generating $124,200 in total proceeds. Upon selling the shares at $41.40, the Director now owns 78,409 shares.

Before that, Petersen Floyd F. sold 500 shares. Amphastar Pharmaceuticals Inc shares valued at $21,326 were divested by the Director at a price of $42.65 per share. As a result of the transaction, Petersen Floyd F. now holds 78,333 shares, worth roughly $2.9 million.

JP Morgan initiated its Amphastar Pharmaceuticals Inc [AMPH] rating to an Overweight in a research note published on March 05, 2024; the price target was $60. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in mid November with a ‘”a Neutral”‘ rating.

Price Performance Review of AMPH

On Tuesday, Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] saw its stock fall -1.02% to $36.99. Over the last five days, the stock has lost -3.95%. Amphastar Pharmaceuticals Inc shares have fallen nearly -40.19% since the year began. Nevertheless, the stocks have fallen -33.85% over the past one year. While a 52-week high of $67.66 was reached on 01/05/24, a 52-week low of $37.00 was recorded on 07/09/24. SMA at 50 days reached $41.23, while 200 days put it at $48.10. A total of 0.72 million shares were traded, compared to the trading of 0.38 million shares in the previous session.

Levels Of Support And Resistance For AMPH Stock

The 24-hour chart illustrates a support level at 36.54, which if violated will result in even more drops to 36.09. On the upside, there is a resistance level at 37.46. A further resistance level may holdings at 37.93. The Relative Strength Index (RSI) on the 14-day chart is 30.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.35%. Stochastics%K at 9.43% indicates the stock is a buying.

The most recent change occurred on July 29, 2022 when CapitalOne began covering the stock and recommended ‘”an Overweight”‘ rating along with a $44 price target.

Most Popular